netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Formulary Chapter 9: Nutrition and blood - Full Chapter
Chapter Links...
 Details...
09.06.07  Expand sub section  Multivitamin preparations
Mutivitamins BPC
View adult BNF View SPC online View childrens BNF
First Choice
Green
  • Capsules containing ascorbic acid 15mg, nicotinamide 7.5mg, riboflavin 500 micrograms, thiamine HCl 1mg, vitamin A 2,500 units, & vitamin D 300 units
 
Dalivit®
View adult BNF View SPC online View childrens BNF
Formulary
Green
  • Drops containing in each 0.6ml dose ascorbic acid 50mg, ergocalciferol
    400 units, nicotinamide 5mg, pyridoxine HCl 500 micrograms, riboflavin
    400 micrograms, thiamine 1mg & vitamin A 5,000 units)
    • Dalivit drops are to be retained for use in patients requiring a full supplement of vitamin A.

 
 
Abidec®
View adult BNF View SPC online View childrens BNF
Alternatives
Green
  • Drops containing in each 0.6ml dose ascorbic acid 50mg, ergocalciferol
    400 units, nicotinamide 5mg, pyridoxine HCL 500micrograms, riboflavin
    400 micrograms, thiamine 1mg & vitamin A 1,333 units.
    To be used in children and adults.
 
 
09.06.07  Expand sub section  Vitamin and mineral supplements and adjuncts to synthetic diets
DEKAs® Essentials multivitamins
View adult BNF View SPC online View childrens BNF
Formulary
Green plus

  • Approved for adult patients requiring multivitamin and mineral supplementation with Cystic Fibrosis

 
 
DEKAs® Plus multivitamins
View adult BNF View SPC online View childrens BNF
Formulary
Green plus

  • Approved for adult patients requiring multivitamin and mineral supplementation with Cystic Fibrosis

 
 
Forceval®
View adult BNF View SPC online View childrens BNF
Formulary
Green plus
  • Capsules
    • For limited use as a vitamin and mineral supplement in patients with phenylketonuria The capsules are also approved as an oral supplement in burns patients with malnutrition or alcohol dependency and patients with major burns after discontinuation of IV therapy, and have also been approved for use in patients with severe anorexia nervosa. Treatment initiated with specialist advice.
  • Soluble
    • Approved for short term use in patients who are unable to swallow
      Forceval capsules.
 
 
Ketovite®
View adult BNF View SPC online View childrens BNF
Formulary
Green plus
 
 
Renavit® tablets
View adult BNF View SPC online View childrens BNF
Formulary
Green plus
  • Water soluble vitamin supplementation therapy for maintenance haemodialysis patients only.
 
 
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Drugs for hospital use only. The responsibility for initiation and monitoring treatment should rest with an appropriate hospital clinician and the drug should be supplied through the hospital throughout the duration of treatment. In some very exceptional circumstances (e.g. due to distance from the hospital, storage, supply or mobility/transport problems) it may be appropriate for the GP to be asked to prescribe a Red drug. This should be negotiated on an individual patient basis and should only be done with the GP’s prior informed agreement where the roles of the GP and hospital services are clearly defined and agreed. The GP should not feel under pressure to prescribe in these circumstances. For all RED drugs automatically added to the formulary in response to a positive NICE TA: Prescribers need to ensure that local Trust new drug governance procedures and pharmacy processes are followed before any prescribing.  

Amber

Drugs initiated by hospital specialist, but where continuing treatment by GPs may be appropriate under a shared care arrangement. The specialist should send the GP a copy of the shared care agreement to sign. The GP should sign the shared care agreement, or indicate they do not want to be part of such an agreement, and return a copy back to the specialist. Shared care guidelines are available or are being developed for most of the drugs listed as Amber. If no shared care guideline is available, the hospital specialist should provide the patient’s GP with sufficient information and support to allow treatment to be continued and managed safely in primary care.  

Green plus

Drugs normally recommended or initiated by a specialist (hospital or GP with an extended role https://www.rcgp.org.uk/gpwer), but can be safely maintained in primary care with very little or no monitoring required. In some cases there may be a further restriction for use outlined - these will be defined in each case. Provision of additional information, or an information leaflet, may be appropriate in some cases to facilitate continuing treatment by GPs.  

Green

Drugs where prescribing by GPs is appropriate. Can be initiated and prescribed in all care settings, and if appropriate, discontinued without recourse to secondary care.  

Black

NOT APPROVED: Drugs that have been considered by NTAG or the NENC ICB Medicines Subcommittee (or other approved body) and are not approved for prescribing within the North East and North Cumbria.   

Brown

UNDER REVIEW: drugs whose current formulary status or RAG status is currently under review.  

Not Recomended

NOT REVIEWED: Drugs that haven not been reviewed yet. This usually means that an application is in progress. These drugs are not normally considered appropriate for prescribing in the North East and North Cumbria until such time that a decision is taken on their formulary status.  

netFormulary